Tokyo, July 3 (Jiji Press)–Japan’s health ministry has ordered Kissei Pharmaceutical Co. to report on 20 deaths among users of Tavneos, a vasculitis drug marketed by the company in Japan, health minister Kenichiro Ueno said Friday. The order was issued on June 19, giving the company, based in the central Japan city of Matsumoto, Nagano Prefecture, until July 21 to submit a report. “We’ll continue to consider our response based on a report from the company and future developments in the United States, where the drug was developed,” Ueno said at a press conference. A U.S. medical journal has retracted an article used to approve Tavneos, at the request of the author after a U.S. Food and Drug Administration investigation detected an inappropriate research method. The European Medicines Agency has recommended revoking the drug’s approval. END [Copyright The Jiji Press, Ltd.]
Kissei Pharmaceutical Ordered to Report on Deaths among Tavneos Users
Related Posts
Chinese Survey Ship Spotted Operating in Japan’s EEZ
Naha, Okinawa Pref., July 3 (Jiji Press)–A Chinese maritime survey ship appeared to be extending a wire into the sea within Japan’s exclusive economic zone on Friday, the Japan Coast Guard said. According to the JCG’s 11th regional headquarters in Naha, the
Japan Tax Revenues Hit Record 84 T. Yen in FY 2025
Tokyo, July 3 (Jiji Press)–The Japanese government’s tax revenues in fiscal 2025 rose 12.0 pct from the previous year to 84,222.6 billion yen, hitting a record high for the sixth consecutive year, the Finance Ministry said Friday. General-account tax revenues in the
